No results for ‘’
BDH Industries Ltd
NSE: BSE: 524828
â‚ą570
(2.70%)
Tue, 28 Jul 2026, 01:48 am
Market Cap (in Cr)319.53
PE Ratio30.35
Dividend0.81
Health Technology
Pharmaceuticals: Other
24.5KBDH Industries Analysis
dividend
- Dividends paid are well covered by earnings (3.4x coverage).
- BDH Industries's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- BDH Industries's dividend is above the markets top 25% of dividend payers in India (3.08%).
- Dividend payments have increased, but BDH Industries only paid a dividend in the past 9 years.
- Whilst dividend payments have been stable, BDH Industries has been paying a dividend for less than 10 years.
health
- BDH Industries is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- BDH Industries is profitable, therefore cash runway is not a concern.
- BDH Industries is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (64.5%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 7.3x debt.
- BDH Industries's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (35.4% vs 16.2% today).
- BDH Industries earns more interest than it pays, coverage of interest payments is not a concern.
- BDH Industries's level of debt (16.2%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- The average tenure for the BDH Industries board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- Jayashree's remuneration is higher than average for companies of similar size in India.
- Jayashree's compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.
misc
- BDH Industries is not covered by any analysts.
past
- BDH Industries's year on year earnings growth rate has been positive over the past 5 years.
- BDH Industries has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- BDH Industries's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- BDH Industries used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- BDH Industries has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- BDH Industries's 1-year earnings growth is negative, it can't be compared to the IN Pharmaceuticals industry average.
value
- BDH Industries is good value based on assets compared to the IN Pharmaceuticals industry average.
- BDH Industries is good value based on earnings compared to the IN Pharmaceuticals industry average.
- BDH Industries is good value based on earnings compared to the India market.
- 524828 outperformed the Market in India which returned -14.5% over the past year.
- BDH Industries's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- BDH Industries's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- 524828 underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
- BSE:524828 is up 1.4% underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:524828 is up 1.4% underperforming the market in India which returned 8% over the past month.